Sampled

Executive Summary

Sampled is a UK-based integrated analytical laboratory and biorepository founded in 2019, offering end-to-end services for biological sample management, storage, analysis, and transport. With over 25 years of collective industry experience, the company serves the diagnostics and digital health sectors, enabling multiomics analysis and streamlined sample logistics. Its platform addresses the growing demand for efficient, high-quality sample handling in precision medicine and clinical research, positioning Sampled as a comprehensive partner for biotech, pharma, and academic clients. Despite limited public information on funding or valuation, Sampled's focus on a critical infrastructure niche in the life sciences value chain suggests potential for growth. As precision medicine expands, the need for reliable biorepository and analytical services is increasing. Sampled's UK base offers access to a robust life science ecosystem and regulatory pathways. However, the lack of disclosed commercial traction or external investment indicates early-stage operations. Key opportunities include forming strategic partnerships with biopharma firms, enhancing lab capacity, and obtaining certifications to differentiate from competitors. The company's trajectory will depend on execution and market adoption.

Upcoming Catalysts (preview)

• H2 2026Strategic partnership with a biopharmaceutical company for multiomics analysis services40% success
• Q1 2027Expansion of laboratory capacity or introduction of new service offerings30% success
• Q3 2026Achievement of ISO 15189 or similar regulatory accreditation50% success